Passa al contenuto
Merck

Developmental enhancers are marked independently of zygotic Nodal signals in Xenopus.

Developmental biology (2014-09-11)
Rakhi Gupta, Andrea Wills, Duygu Ucar, Julie Baker
ABSTRACT

To determine the hierarchy of transcriptional regulation within the in vivo vertebrate embryo, we examined whether developmental enhancers were influenced by Nodal signaling during early embryogenesis in Xenopus tropicalis. We find that developmental enhancers, defined by the active enhancer chromatin marks H3K4me1 and H3K27ac, are established as early as blastula stage and that Smad2/3 only strongly associates with these regions at gastrula stages. Significantly, when we perturb Nodal signaling using the drug SB431542, most enhancers remain marked, including at genes known to be sensitive to Nodal signaling. Overall, as enhancers are in an active conformation prior to Nodal signaling and are established independently of Nodal signaling, we suggest that many developmental enhancers are marked maternally, prior to exposure to extrinsic signals.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
L-lisina, ≥98% (TLC)
Sigma-Aldrich
L-lisina, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
L-lisina, crystallized, ≥98.0% (NT)
Sigma-Aldrich
L-lisina, reagent grade, ≥98% (HPLC)
Sigma-Aldrich
L-Lysine acetate salt, ≥98% (HPLC)
Supelco
L-lisina, analytical standard
Supelco
L-lisina, Pharmaceutical Secondary Standard; Certified Reference Material
L-lisina, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
L-lisina, BioUltra, ≥99.5% (AT)
Supelco
L-lisina, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Supelco
L-Lysine Acetate, Pharmaceutical Secondary Standard; Certified Reference Material
Lysine acetate, European Pharmacopoeia (EP) Reference Standard